Zepto Life Technology is a pioneering brand dedicated to revolutionizing diagnostic technology. With a focus on innovation, they have developed a highly-sensitive and multiplexed immunoassay and molecular diagnostics platform. This cutting-edge technology enables fast disease diagnosis and facilitates medical interventions using a handheld device.

At the heart of Zepto Life's groundbreaking technology is the giant magnetoresistance (GMR) principle, a Nobel Prize-winning concept in Physics. The company exclusively licensed this biosensing technology from the renowned University of Minnesota. Headquartered in St.

Paul, Minnesota, Zepto Life Technology has been designing and developing its proprietary Gigantic Magneto-Resistance (GMR) biosensing chips, on-chip bio-surface technology, magnetic nanoparticle immunoassay, and microfluidic technology since 2014. Zepto Life's flagship product is a handheld diagnostics system that measures D-Dimer levels, aiding in the diagnosis of venous thromboembolism (VTE) and excluding deep vein thrombosis (DVT) and pulmonary embolism (PE). The company ensures lab-quality results, simplicity, versatility, and product quality, instilling confidence and trust in their customers.

Furthermore, Zepto Life is actively engaged in advanced research and development to expand its product portfolio to include molecular diagnostics alongside protein biomarkers technology. With a strong emphasis on manufacturing processes, Zepto achieves scalable production volume, delivering compact, low-cost, and reliable products. To learn more about Zepto Life Technology and their innovative solutions, visit their website or contact them directly.

They are passionate about transforming healthcare and making a lasting impact in the field of diagnostics